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Canine  tracheal  epithelial cells freshly  isolated  from 
mongrel  dog  trachea  were used to  study  relationships 
between  arachidonic  acid metabolism and chloride  ion 
movement.  High performance  liquid  chromatography 
(HPLC)  analysis of the cell  incubation  media after  the 
addition of A23187 showed the  presence of prostaglan- 
din H synthase  and  lipoxygenase-derived metabolites. 
The major  prostaglandin H synthase  metabolite  iden- 
tified  by  HPLC,  gas  chromatography,  and  mass spec- 
trometry  was  prostaglandin (PG) D,. The  major  lipox- 
ygenase metabolites were leukotriene (LT) C4 and 
LTB,. LTB, was identified  by  HPLC, UV spectroscopy, 
and gas chromatography.  Straight  phase HPLC of the 
methyl  esters  indicated  only a minor  formation of LTB, 
isomers. LTC, was  identified  by HPLC, UV spectros- 
copy, and conversion to LTD, by  yglutamyl  transpep- 
tidase.  Analysis  by  radioimmunoassays  indicated  ap- 
proximately 1-2 ng of LTB, and peptide LT formed  by 
10‘ cells after A23187 stimulation. The addition of 
ionophore A23187 caused a rapid  release of arachi- 
donic  acid  metabolites  which  was  completed  within 5 
min of stimulation. C1- secretion  was  measured  in par- 
allel  studies of excised  tracheas  in Ussing  chambers. 
C1- secretion  occurred a t  2-3 min after  the  addition of 
ionophore, and  the most rapid  change  occurred  with 
the highest PGDz concentrations. Indomethacin pro- 
duced a concentration-dependent  inhibition of PGD, 
formation  and C1- movement. The  addition of PGE,, 
PGDz, and PGH, effectively  stimulated C1- secretion. 
LTC, also  stimulated C1- secretion,  but  the  stimulation 
was  inhibited by indomethacin.  These  results  indicate 
that  canine  tracheal  epithelial  cells metabolize arachi- 
donic  acid via  both  prostaglandin H synthase  and li- 
poxygenase  enzymes. It appears that endogenous  PGDz 
formation is the  important  variable  controlling  the C1- 
ion movement in  canine  trachea. 
Lung  diseases  are  often  characterized by derangements of 
the mucin and  water  content of airway secretions. The water 
content of airway secretions is modulated by active  ion  trans- 
port  systems located in airway epithelia.  The  control of these 
transport processes in  health  or disease is  not known (1-3). 
* The costs of publication of this article were defrayed in part by 
the payment of page charges. This article  must therefore be hereby 
marked “advertisement” in accordance with 18 U.S.C. Section 1734 
solely to indicate this fact. 
5 To whom all correspondence should be addressed. 
)I Supported by Research Grant HL-22924 from the National In- 
stitutes of Health and  the Specialized Centers for Research Grant 
HL-34322. An established investigator of the American Heart Asso- 
ciation. 
Previous work suggests that  arachidonic acid  metabolism has 
a role in controlling the rate of  C1- secretion by canine 
trachea, a frequently used model for studying airway ion 
transport.  The  addition of PGEtl  or PGF,, to excised canine 
tracheas stimulates C1- secretion while indomethacin and 
other  prostaglandin H synthase  inhibitors  depress C1- secre- 
tion  across  the airway epithelia (4-6). The  addition of Ca2+ 
ionophore, A23187, which stimulates the release of arachi- 
donic  acid and  the  subsequent  metabolites  also increased C1- 
secretion (4). Arachidonic  acid metabolites  are also  implicated 
in  the regulation of mucus secretion. Studies  have shown that 
PGF,, and more recently  LTC4  and LTD, stimulate mucus 
production  in  cat  trachea  (7),  in dog trachea in oiuo (8), and 
in  human airways in  vitro (9). 
In  the  present  study, we have  sought  to identify the 
source(s) of AA metabolites  that may affect  airway epithelial 
function.  Preliminary  reports  have suggested that  the  epithe- 
lial  cells themselves may  form a spectrum of  AA metabolites. 
Smith  and co-workers (4) measured the release of a prosta- 
glandin  into  the  luminal  bathing  solution of canine  tracheas 
mounted  in  conventional ion  flux (Ussing) chambers. On  the 
basis of radioimmunoassay data, they identified this com- 
pound  as  PGE2.  More recently, Holtzman et al. (10) reported 
that freshly isolated  epithelial cells  from dog tracheas  synthe- 
size LTB4 from exogenous arachidonic acid. Therefore,  in  the 
present  study we have evaluated  the  hypothesis  that isolated 
airway epithelial cells  metabolize  endogenous arachidonic acid 
in  significant  quantities via both  prostaglandin H synthase 
and lipoxygenases and  that  the  metabolites formed play an 
important role in  controlling  the volume and composition of 
airway secretions. The experimental design was 1) to  char- 
acterize the endogenous arachidonic acid metabolites pro- 
duced  by  isolated  airway epithelial cells after  stimulation with 
the Ca2+ ionophore, A23187, and 2) in parallel studies to 
measure  the  changes  in C1- secretion  and endogenous arachi- 
donic  acid  metabolism under  various  experimental  conditions. 
The  canine  trachea was  selected  for these  studies  as a useful 
model system because of the availability of relatively large 
The abbreviations used are: PGs, prostaglandins; LTA,, leukotri 
ene A,, 5S,6S-oxido-7,9,11,14(E,E,Z,Z)-eicosatetraenoic acid; 
LTB4, leukotriene B4, 5S,12R-dihydroxy-6,8,10,14(Z,E,E,Z)-eicosate- 
traenoic acid; LTC,, leukotriene C,, 5s-hydroxy-6R-S-glutathionyl- 
7,9,11,14(E,E,Z,Z)-eicosatetraenoic acid; 5S,12S-diHETE, 5S,12S- 
dihydroxy-6,8,10,14(E,Z,E,Z)-eicosatetraenoic a id; 5-HETE,  5s-hy- 
droxy-6,8,10,14(E,Z,Z,Z)-eicosatetraenoic a id; 12-HETE,  12s-hy- 
droxy-5,8,10,14(Z,Z,E,Z)-eicosatetraenoic acid; 15-HETE,  15s-hy- 
droxy-5,8,11,13(Z,Z,Z,E)-eicosatetraenoic a id; RP-HPLC, reverse- 
phase high performance liquid chromatography; HETES, hydroxyei- 
cosatetraenoic acids; Isc, short circuit current; G, conductance, AA, 
arachidonic acid. 
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numbers of normal airway  epithelial  cells and the  background 
information of C1- secretion  in  the  tissue (4,8, 9). 
EXPERIMENTAL  PROCEDURES 
Materials-The [5,6,8,9,11,12,14,15-3H]arachidonic acid (83.8 Ci/ 
mmol) and [l-'4C]arachidonic acid (56 Ci/mol), PGs, 5-HETE, 15- 
HETE, leukotriene C, (LTC,), leukotriene D, (LTD,), and radioim- 
munoassay ki t  for LTC, were obtained from New England Nuclear. 
[3H]Leukotriene B, (LTB,) and [14C]PGF2, were obtained from 
Amersham Corp. Unlabeled LTC,, LTB,, LTD,, LTE4, and LTF, 
were gifts of Dr. J .  Rokach (Merck Frosst Laboratories, Quebec, 
Canada). 
Dithiothreitol, y-glutamyl transpeptidase,  glutathione,  indometh- 
acin, ibuprofen, naproxen, methoxylamine HCl, diisopropyl ethyla- 
mine, and pyridine were obtained from Sigma. Trypan blue was 
obtained from Gibco Laboratories. The calcium ionophore, A23187, 
was purchased from Behring Diagnostics. Collagenase was obtained 
from Worthington. The Pentobarbital was purchased from Barber 
Veterinary Supply (Fayetteville, NC). Glutaraldehyde, paraformal- 
dehyde, osmium tetroxide, toluidine blue, and uranyl acetate were 
obtained from Fisher. 
Pentafluorobenzyl bromide was purchased from Supelco, Inc. (Bel- 
lefonte, PA). Bis(trimethylsily1)trifluoreoacetamide containing l% 
trimethylchlorosilane was obtained from Bodman Chemical (Media, 
PA). Diethyl ether was purchased from Mallinckrodt Chemical 
Works. N-methyl-N'-nitro-N-nitrosoguanadine was purchased from 
Sigma. 
HPLC grade methanol, HPLC grade acetonitrile, and  HPLC grade 
hexane were obtained from Fisher while HPLC grade water was 
purchased from EM Industries Inc. (Gibbstown, NJ). 
Pellicular CIS glass beads (37-53 pm) were used for the packing in 
the precolumn (Whatman). Ethylenediaminetetraacetic acid diso- 
dium salt  dihydrate  (EDTA) was purchased from Aldrich. Atomlight 
(New England Nuclear) and Hydrofluor (National Diagnostics, Som- 
merville, NJ) were used as  the scintillation mixtures. 
Canine Tracheal Epithelium Isolation-Male mongrel dogs  (15-25 
kg) or male beagle  dogs (Marshall  Farms, N.  Rose,  NY)  were put  to 
death with intravenuous pentobarbital (120 mg/kg). The tracheas 
were rapidly excised through a midline incision and bathed  in iced 
Krebs-Ringer bicarbonate solution which was gassed continuously 
with 95% 0,/5% CO,. Excess connective tissue and the posterior 
membranous portion were  removed  by sharp dissection. The cartilag- 
inous portion was cut  into 3 X 3-cm segments. A solution of 0.5% 
dithiothreitol and 0.25% collagenase (150 units/mg)  in Krebs-Ringer 
bicarbonate solution was injected submucosally with a 27-gauge 
needle. Care was taken to rid the submucosal space of blood  via this 
maneuver. The segments were then floated on a 0.5% dithiothreitol 
solution in glass Petri dishes and incubated for 45 min in a 37 'C 
shaking incubator, gassed with 95% 02/5% CO,. The epithelium was 
then removed as sheets by gently scraping the mucosal surface with 
glass coverslips into Ca2+-Mp2+-free Krebs-Ringer bicarbonate solu- 
tion and placed on ice.  Cell yield was 0.7-3 X 10' cells/trachea, with 
viability >95% by trypan blue exclusion. 
Morphology Studies-Epithelial cells were placed in buffered (pH 
7.4) glutaraldehyde paraformaldehyde fixative and kept at 4 "C until 
further processed. The samples were washed in 0.2 M phosphate 
buffer, pH 7.4, and postfixed in phosphate-buffered 1% 0.50, for 2  h, 
dehydrated in alcohol and propylene oxide, and embedded in Epon 
812. Thick sections (0.5 p )  for light microscopy were cut with a 
Sorvall MT-I ultramicrotome and stained with toluidine blue. Thin 
sections, 400-600 8, by interference color, were stained with uranyl 
acetate and Reynold's lead citrate and examined with a  Philips 400 
electron microscope. 
Incubation Conditions-The epithelial cells were suspended in 
Ca2+-MgZ+-free Ringer's solution at 37 "C. Cells were divided into 
several 2-ml aliquots containing 1-2 X lo6 cells, the equivalent of 
tion (16). [3H]Arachidonic acid (5 pCi (87 Ci/mmol)) was added to 
2.0-5.5 mg/ml protein as determined by a Lowry protein  determina- 
the cells for 1 h prior to stimulation.  Preliminary  experiments had 
established the incorporation time of arachidonic acid into the phos- 
pholipid pools by measuring the disappearance of radioactivity from 
the media containing the isolated cells. Maximum incorporation 
occurred between 1 and 2  h as reflected by the loss of radioactivity 
from media. Incorporation of [3H]arachidonic acid into the phospho- 
lipid pools was confirmed by extracting with ch1oroform:methanol 
(21) and analyzing the lipids by thin layer chromatography (17). 
TLC chromatograms indicated that between 50 and 60% of the [3H] 
arachidonic acid added was incorporated into  the phospholipid pools. 
After the incorporation of [3H]arachidonic acid, the cells were 
washed twice with Ca2+-Mg2f-free Ringer's solution at  4 "C. Ringer's 
solution containing 1 mM CaC12 and 1 p~ A23187 at 37 "C was then 
added to  the cells. The cells were incubated for 5 min at 37 "C and 
then placed immediately in ice and centrifuged at 9,000 X g at 10 "C 
for 10 min. An internal standard ([14C]PGF2,;  10,000 dpm) was added 
to  the supernatant. The  supernatant was added to 8 ml of cold ethanol 
bringing the final solution to 80% ethanol. The supernatant was 
centrifuged at 10,000 X g for 20 min at 10 "C to precipitate the 
protein. The supernatant was removed, evaporated under N2, and 
reconstituted  in 1 ml of 30% MeOH:H20. Before injecting the sample 
on the reverse phase HPLC, the samples were centrifuged for 5 min 
in an Eppendorf centrifuge 5412 (Brinkmann Instruments).  The cell 
pellet was dissolved in 1.0  ml  of  0.1 N NaOH for protein determina- 
tion. 
then were suspended in 6 ml of CaZ+-Mg2+-free Ringer's solution at 
In large scale incubations, the cells from 2-5 dogs  were  pooled and 
37 "C. [3H]Arachidonic acid (15 pCi) was incorporated into the cel- 
ditions  are as described above. The  internal standard of [14C]PGFz, 
lular phospholipids pools. Incubation, washing, and  stimulation con- 
(20,000 dpm) was added to the supernatant. The supernatant was 
added to 24 ml of cold ethanol bringing the final solution to 80% 
ethanol. The supernatant was prepared for HPLC analysis as de- 
scribed above. In other experiments, cells were incubated with [ 1-"C] 
arachidonic acid, ethanol was added, and  the  supernatant prepared 
for HPLC analysis. For indomethacin studies, [3H]arachidonic acid 
was incorporated for 1 h  in Ca2+-Mg2+-free Ringer's and washed twice. 
Indomethacin was added for 2 min at 37 "C, following  which 1 mM 
CaCh and  A23187,l p ~ ,  were added. The cells were incubated for 5 
min at 37 "C, and  the  supernatant was prepared for HPLC analysis 
was described above. 
Arachidonic acid metabolites produced from these large scale in- 
cubations were separated by reverse phase HPLC using solvent 
system 1 or 2. The individual metabolites were collected, pooled, the 
solvent removed and subjected to further analysis. UV spectra were 
measured using a  Hewlett-Packard 8450 spectrophotometer with the 
sample dissolved in 30% MeOH:H20. 
Separation of Metabolites-A Waters HPLC system consisting of 
a model  U6K injector, two model 6000A solvent delivery pumps, Z 
module radial compression model, a model 720 system controller, and 
a model  441 absorbance detector set  at 280 nm (Waters Associates, 
Milford, MA)  was used for all HPLC methods. A Radiomatic radio- 
active flow detector was used to determine radioactivity in the  eluant 
in 30-s fractions (Radiomatic Instruments and Chemical Co. Inc., 
Tampa, FL). Hydrofluor and Atomlight were used as  the scintillation 
fluids. For some experiments, fractions were collected by a fraction 
collector, and  the radioactivity was determined by a  Packard 460C 
using quench curves and internal  standardization. Radioactivity in 
the eluant was convereted to dpm/fraction. 
Solvent systems 1 and 2 were used to separate prostaglandins, 
leukotrienes, and  HETES (13). For solvent system 1 separation was 
achieved on a reverse phase Waters  Radial-Pak cartridge CIS (5 pm; 
8 mm, inner  diameter) at 3 ml/min. Solvent system 2 used a reverse 
phase Altex CIS (5 pm; 4.6 X 250 mm, Beckman, Berkeley, CA) at 1 
ml/min. A precolumn packed with Whatman 37-53-pm pellicular CIS 
beads was used in both systems. 
Solvent system 1 used methanol and water buffered to pH 5.8 with 
NH,OH and 0.01% acetic acid as  the mobile phase. This system used 
a  four-step gradient of  49, 57,  65, and 100% methanol in water over 
60 min changing the steps at  15,30,  and 50 min. The solvent system 
2 used a  four-step gradient of 53,60, 73, and 100% methanol in water 
over 100 min changing at  27,52, and 74 min. The water was buffered 
to pH 5.05 with 0.02% glacial acetic acid and NH,OH, and then 
methanol was added to bring the concentration of methanol to 10%. 
Solvent system 3 was used to separate prostaglandins and HETES. 
Separation was achieved on a reverse phase Waters Radial-Pak 
cartridge CIS (10 pm; 5 mm, inner diameter) a t  3 ml/min. Acetonitrile 
and water buffered with 1% acetic acid and NH,OH to  pH 3.5 was 
used as  the mobile phase. Samples were eluted from the column with 
a three-step gradient of 26, 50, and 100% acetonitrile over 55 min 
changing at  25 and 45 min (14). 
stereoisomer 5SJ2S-diHETE. Separation was achieved with a  What- 
Solvent system 4 was  used to separate LTB, methyl ester from its 
man straight phase column (25 cm X 4.6 mm, inner diameter; 10-pm 
particles) at 1 ml/min. Ethanol/hexane/acetic acid, 5:95:0.01 (v/v) 
was  used as  its mobile phase (15). 
Metabolism of Peptide Leukotrienes by y-Glutamyl Transpepti- 
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dme-The isolated peak 5 tentatively identified at LTC, was dis- 
solved in 0.1 ml  of 0.1 M Tris. HCl, pH 8.5, containing 0.01 M MgC1,. 
y-Glutamyl  transpeptidase, 0.2 mg/ml, was added to  the mixture and 
incubated for 30 min at 37 "C. Authentic LTC, was also incubated 
under the same  conditions in parallel experiments. Methanol (0.1 ml) 
with 5.0% acetic acid was added to stop the reaction. The sample was 
injected directly onto  a reverse phase HPLC column using solvent 
system 1 to determine the conversion to LTD, (18). 
Peak 6 tentatively identified as  LTDr was dissolved in 0.1 ml of 
0.1 M Tris.HC1, pH 8.5, containing 0.01 M MgCl, and 8 mM gluta- 
thione. Cold authentic LTD,, 3 p ~ ,  was added to  the mixture. y- 
Glutamyl transpeptidase, 0.2 mg/ml, was added, and  the sample was 
incubated for 30 min at  37 "C. Methanol (0.1 ml) with 5.0% acetic 
acid was added to stop the reaction. The sample was injected onto  a 
RP-HPLC column using solvent system 1 to determine the conversion 
Separation of LTB, and (5S,12S)-diHETE Methyl Esters-The 
arachidonic acid metabolite tentatively identified as LTB, was sepa- 
rated by reverse phase HPLC using either solvent system l or 2. The 
LTB, peaks were pooled, evaporated under N,, and treated with 
diazomethane in diethyl ether  as described by Fels et al. (15). Au- 
thentic LTB, was also treated in the same manner. The resulting 
methyl esters were analyzed by normal phase HPLC using solvent 
system 3 as described previously. 
Analysis by Gas Chromatography-Mass Spectrometry-The individ- 
ual metabolite peaks were collected from columns using solvent 
system 1 or 2. In some cases the  entire incubation mixture was  used. 
After the removal of the solvent by evaporation, the metabolites were 
further purified by elution of C-18 Sep-Paks  as described previously 
(11). The purified metabolites were esterified with pentafluorobenzyl 
bromide in the presence of diisopropyl ethylamine at room tempera- 
ture. After the removal of the solvent, the esters were reacted with 
methoxylamine in pyridine, and  the resulting derivatives were repu- 
rified on a silica Sep-Pak. The repurified metabolites were tri- 
methylsilylated with bis(trimethylsily1)trifluoroacetamide:trimethyl- 
chlorosilane, 99:l. 
A Varian gas chromatograph modified for fused silica capillary 
columns (30  m X 0.25 mm, inner  diameter; DB-5 fused silica (J. W. 
Scientific)) was used. The temperature of the injector was set at 
250 "C, and  the detector was set  at 330  "C. The column was heated 
to 200 "C for 3 min, then increased to 300 "C at 5  "/min, and held at 
300 "C for 15 min. The metabolites were detected by a constant 
current-pulse modulated electron capture detector. Negative ion 
chemical ionization-mass spectrometry with argon as  the reagent gas 
was performed using a VG 7070E mass spectrometer equipped with a 
VG  2050 data system, a 30-m DB-4 fused silica capillary column, and 
split/splitless injector (1O:l) .  
Radioimmunoassay for  Leukotrienes-The quantity of LTB, and 
LTC, produced by dog tracheal epithelial cells was estimated by 
radioimmunoassay. Specific antisera to LTB, and peptide leuko- 
trienes were used to  quantitate LTB, and LTC, as described previ- 
ously (19). The media from the cell incubations described above  was 
assayed directly a t  3  or more dilutions. The cross-reactivities and  the 
method of analysis are as described previously (19). In all cases, the 
dilution curves for biosynthetic LTB, and LTC,  were parallel to  the 
standard curves. In other experiments, the chromatographic peak (see 
Fig. 2) which eluted with authentic LTC,  was evaporated, redissolved 
in buffer, and analyzed for LTC, by radioimmunoassay. The dilution 
curve for biosynthetic LTC, was parallel to  the  standard curve. 
Metabolism of LTC, by Epithelial Cells-Freshly isolated epithelial 
cells were suspended in Ca2+-Mg2+-free Ringer's solution and divided 
into 2-ml aliquots  containing 2 X lo6 cells. Cells were then sonicated 
for 30 s at a constant 4 "C. [3H]LTC4 (0.1 pCi) and sufficient unlabeled 
LTC, to achieve a  final  concentration of 0.1 p~ were added to  the 
sonicate. A23187, 1 pM, and CaC12, 1 mM, were then added, and  the 
mixture was incubated for 5 min at 37 "C. The reaction mixtures 
were  cooled to 0 "C, and  the samples were prepared for HPLC analysis 
as described above. 
Bioelectric Measurements and Solute Permeabilities-The posterior 
membranes of freshly excised dog tracheas were placed in chilled 
(4 "C) Krebs-Ringer bicarbonate solution, stripped of the trachealis 
muscle and  the submucosal tissue by sharp dissection, and mounted 
in Lucite flux chambers (1.13 cm'). The tissues were continuously 
exposed to warmed (37 "C)  and gassed (95% O,, 5% CO,) Ringer's 
solution. The transepithelial electric potential difference and  the DC 
current required to null the potential difference to zero (short circuit 
current (Isc)) were measured as previously described (3) and the 
conductance (G) calculated. In most instances, the basal bioelectric 
to LTC, (18). 
properties were  allowed to stabilize for 60 min after mounting. The 
tissues assigned to protocols were matched on the basis of G (<0.5 
ms.cm-' difference) and Isc (e20 pA.cm-' difference). For dose- 
response studies, A23187 was added cumulatively from 3 X lo-* to 
M, with Isc recorded continuously. These  studies showed that 
the relationship between A23187 concentration and C1- secretion was 
steep, and M ionophore induced the maximal effect. For the time 
course studies, a single maximal effective concentration M) was 
added, and  the Isc was measured continuously for 15 min. Ionophore 
additions were bilateral. The dose-effect relations between Isc and 
indomethacin were also explored. Indomethacin to 3 X M) 
dissolved in dimethyl sulfoxide was added to both mucosal and 
submucosal bathing solutions, and  the Isc  was recorded for 60  min. 
A23187 M) was added to each chamber, and the Isc was recorded 
for an additional 30 min. To compare potencies of PGs, LTs, and 
HETEs,  the following protocols were employed 1) for PGs, the tissues 
were pretreated with indomethacin (1O"j  M) for 60 min prior to  PG 
addition to minimize basal PG generation and Isc; all additions were 
bilateral, cumulative, and ranged from lo-" to M; 2) for exposure 
to  HETE  and LTs, no pretreatment was performed; the additions 
were bilateral and cumulative. All effects were compared to vehicle- 
exposed time  control tissues. Because the effect of LTC, on Isc in 
canine  trachea  has not been fully characterized, seven tissue pairs  (G 
and Isc matched) were used to quantitate the effects of LTC, on 
unidirectional permeabilities of ["NaJ-, [36C1]-, and ['4C]mannitol as 
previously described (3). Basal fluxes (60-120) were measured, and 
then  the effects of LTC, on bioelectric properties and solute flows 
were measured over four 15-min intervals. Finally, to explore the 
interactions between LTC, effect and PG synthesis, tissues were 
either  pretreated with indomethacin or  other cyclooxygenase inhibi- 
tors (3 X M) and then exposed to LTC, or exposed to indometh- 




Sheets of cells isolated from dog trachea by enzymatic 
dissociation exhibited greater than 95% viability as deter- 
mined by trypan blue exclusion. In addition, viewing grids 
prepared from  seven separate  preparations showed no 
( ~ 0 . 1 % )  contamination of epithelial cells by leukocytes or 
macrophages (>lo00 cells counted/specimen). Further ex- 
amination of these  grids  did  not  indicate  contamination by 
mast cells. Thick sections were stained with toluidine blue 
and examined by light microscopy. Numerous goblet cells 
staining blue were observed while mast cells  which stain  red 
or red blue were not observed. Examination of >lo00 cells 
from four different dog preparations  indicated  no  significant 
contamination by mast cells. Fig. 1 shows  a  typical electron 
micrograph of these  canine  epithelial cell preparations.  One 
observes well preserved ultrastructure,  with  intracellular  tight 
junctions  intact,  and  normal  appearing nuclei, mitochondria, 
and cilia. After A23187 stimulation, cell viability was not 
altered  (trypan blue  exclusion, 95%, n = 7). 
PHIArachidonic Acid Metabolism 
The dog tracheal  epithelial cells  rapidly incorporated ['HI 
arachidonic acid into  the cellular  phospholipid. The maximum 
incorporation  into  the  phospholipids was obtained  after 1 h 
of incubation,  and  thus  this  incorporation  time was used in 
all subsequent experiments. After  washing the cells  with 
buffer to remove unincorporated arachidonic acid and its 
metabolites,  the  addition of calcium-containing media and 1 
PM A23187 induced a rapid release of arachidonic acid and  its 
metabolites.  Analyses of the media  from the  epithelial cells 
by RP-HPLC (Fig. 2) shows the presence of 10  metabolites 
in  addition  to  arachidonic a id. However, most of these  peaks 
were minor  metabolites,  and only  four  major metabolites were 
routinely observed. Three of the  four major metabolites co- 
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A B 
FIG. 1. A, transmission electron micrograph of an epithelial  preparation.  The  integrity of the epithelium is 
maintained,  and  relatively  normal  appearing columnar ciliated  and  nonciliated  cells are observed (X 2700). B, 
transmission  electron  micrograph of ciliated  cells from an epithelium.  The  intercellular tight junctions remain 
intact. Although the endoplasmic  reticulum is somewhat  dilated,  the  nuclei,  mitochondria, and cilia appear normal 
(X 5120). 
eluted with authentic standards of PGE,/PGD, (Peak 3), 
LTC, (Peak 5), and LTB, (Peak 7). The fourth metabolite, 
Peak 6, did not co-elute with any  authentic  standard available. 
The analyses of the arachidonic acid metabolites by RP- 
HPLC showed variability in  the metabolite profile between 
dog tracheal  epithelial cell preparations. The  tentative iden- 
tification of the metabolites and  the variability between ex- 
periments  is shown in Table I. The minor metabolites, for the 
most part, were only occasionally observed and, therefore, not 
rigorously characterized. The  tentative identification of these 
minor metabolites is based on co-elution with authentic  stand- 
ards (see Table I). 
Identification of Major Metabolites 
Peak 3-This metabolite co-eluted with authentic PGE, 
and PGD,  on both solvent systems 1 and 2, and  the formation 
of metabolite 3 by the dog tracheal epithelial cells was inhib- 
ited by the prior addition of indomethacin. The peak was 
collected and rechromatographed using solvent system 3 
which separates PGE, and PGD,. Peak 3 eluted with the same 
retention times as authentic PGD,.  As seen in Fig, 3, Peak 3 
clearly separated from the authentic [3H]PGE2 which was 
added to the sample. Peak 3, isolated from RP-HPLC using 
solvent system 1, was derivatized to  the pentafluorobenzyl 
estermethoxine-trimethylsilane ether  and  run on a gas chro- 
matograph as described under “Experimental Procedures.” 
Negative ion chemical ionization mass spectrometry, using 
argon as  the reagent gas, produced fragmentation patterns 
and high molecular weight anions  characteristic of derivatized 
PGD,. Fig. 4 is  a negative ion chemical ionization mass spectra 
as  the pentafluorobenzylester-methoxine trimethylsilane de- 
rivatives of authentic PGD, (A) and  the sample (B). The mass 
at m/z 524 corresponds to the carboxylate anion (“181) 
resulting from the loss of the pentafluorobenzyl group. Losses 
of trimethylsilanol (m/z 90) from C9 and C15 appear at mass 
m/z 434 and 344. Derivatized authentic PGD, and peak 3 
gave identical retention  times  on gas chromatography. Also 
authentic derivatized PGE2 gave major ion at 524 (data  not 
shown). 
Peak 5-Peak 5 co-eluted on solvent systems 1 and 2 with 
an  authentic  standard of  LTC,. The formation of this metab- 
olite was not  inhibited by the addition of indomethacin to the 
incubation mixture. As seen in Fig. 2, peak 5 also absorbed at 
280 nm suggesting a conjugated leukotriene. After the collec- 
tion of peak 5, the solvent was  removed, and  the sample was 
dissolved in methanol. The characteristic UV spectra of pep- 
tide leukotrienes, with a peak at  280 nm and shoulders at 270 
and 292 nm, were  observed (20, 21). The metabolite of peak 
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FIG. 2. Reverse phase HPLC chromatographic profile for 
[3H]arachidonic acid metabolites produced by dog tracheal 
epithelial  cells. [3H]Arachidonic acid was incorporated into cellular 
phospholipid and released by the addition of ionophore, A23187. 
Metabolites were prepared for analysis as described under “Experi- 
mental Procedures” and chromatographed on solvent system 2. Elu- 
tion of authentic  standard is indicated. The individual metabolites 
were isolated and subjected to  further analysis. 
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TABLE I 
Arachidonic  metabolites  produced  by dog epithelial cell preparations 
Peaks Retention  Total  m tabolites Designation 
time (x f S.D.; n = 7) m/z 
FIG. 4. Characterization of metabolite 3 as PGD2. A ,  mass 
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FIG. 5. Metabolism of metabolite 5 to LTD4 by y-glutamyl 
transpeptidase. Metabolite 5 was dissolved in 0.1 ml of 0.1 M Tris. 
HCI with 0.1 M MgCI,, pH 8.5.  0.2  mg/ml y-glutamyl transpeptidase 
was added and incubated for 30 min at 37 “C. 0.1 ml of MeOH + 
5.0% acetic acid was added to stop the reaction, and an aliquot was 
injected onto the HPLC column. Authentic LTC, treated in an 
identical incubation was metabolized to  LTDa.  The arrow indicates 
elution time of standards. 
5 was further  characterized by enzymatic digestion with y- 
glutamyl transpeptidase (?-GTP) which converts LTC, to 
LTD, (18). Peak 5 was incubated with r -GTP  as  described 
under  “Experimental Procedures.” Authentic LTC, was con- 
verted to  a metabolite which co-elutes  with authentic  LTD, 
(data  not  shown). Likewise, Peak 5 was also  metabolized by 
y-GTP to a product which co-eluted with authentic LTD, 
Time I min 1 
FIG. 3. Reverse phase HPLC analysis of metabolite 3. Me- 
tabolite 3 separated and isolated as described in Fig. 2 was chromat- 
ographed on solvent system 3. The arrow indicates the elution times 
of PGE2  and PGD2. The solid line is metabolite 3; the dashed line is 
an  internal  standard of [3H]PGE2. 
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FIG. 6. Characterization of metabolite 7 as LTB,. A, UV spectrum of metabolite 7 in methanol. B, straight 
phase HPLC  separation of LTB, from 5S,lPS-HETE. Metabolite 7 was  converted to the methyl ester derivatives 
and chromatographed  using  solvent  system 4. 
(Fig. 5). Peak 5 prepared using [l-'4C]arachidonic acid was 
analyzed  LTC, by radioimmunoassay.  Peak 5 contained  im- 
munoreactive material with a dilution curve parallel  to  the 
standard.  Thus,  the  arachidonic acid metabolite  in peak  5 is 
LTC,. 
Peak 6"The formation of the arachidonic acid metabo- 
lite(s)  present  in  peak 6  was not  inhibited by the  addition of 
indomethacin to the incubation mixture. The metabolite(s) 
eluted at approximately 47 min in solvent system 2, which 
did not co-elute with any authentic leukotriene available. 
LTF,  and  LTE,  eluted  at 43 and  55  min, respectively, while 
the  l l - t rans  isomers of LTC,  and LTD, elute  approximately 
1 min before the  corresponding  parent leukotrienes. Peak 6 
isolated and repurified by HPLC had a characteristic UV 
spectra  with  maximum  absorbance at 280 nm  and  shoulders 
at  272 and 293 nm  (data  not  shown).  The  metabolite(s) was 
apparently  not a sulfoxide leukotriene which has a maximum 
absorbance at 284 nm  (22)  nor a sulfone which absorbs a t  280 
nm  but  elutes 1-2 min  earlier  than  the  corresponding leuko- 
triene (22,  23) on reverse phased  HPLC. 
LTD, is converted  to  LTC, by y-glutamyl  transpeptidase 
in  the  presence of reduced glutathione (18). Authentic  LTD, 
and peak 6, repurified  by  reverse phase  HPLC, were treated 
with  y-glutamyl  transpeptidase  and  GSH. The  authentic 
LTD, added to  the  incubation  mixture was converted  to LTC, 
while the  metabolite,  peak  6, was not metabolized to LTC,. 
These data suggest that peak 6 is not LTD,. Furthermore, 
LTC,, LTD,, or LTE,  incubated  in  the  presence of ionophore 
with cells was not  converted  to  peak 6 or other  products  (data 
not  shown).  Identification of this  arachidonic acid metabolite 
was complicated by the  variability of the  biosynthesis  in  the 
experiments which may be a reflection of the variability 
among mongrel dogs. 
Peak 7-The formation of the  arachidonic acid metabolite 
in  peak 7 was not  inhibited by the  addition of indomethacin 
to  the incubation  mixture.  Peak 7 co-eluted  in  systems 1 and 
2 with authentic LTB,, and UV absorption at 280 nm was 
detected. The isolated peak showed a characteristic leuko- 
triene  spectrum  similar  to  authentic  LTB, (Fig. 6 A )  with a 
maximum absorbance at 270 nm  with  shoulders at 262 and 
281 nm. Since our  RP-HPLC does not  separate  LTB, from 
its isomers,  (12, 15) the purified metabolite was converted to  
a methyl  ester  and  analyzed by straight  phase  HPLC. As seen 
in Fig. 6B the metabolite, peak 7, co-eluted with authentic 
LTB,  methyl  ester  and showed  only a minor  contamination 
with the 5S,12S-diHETE. After conversion to pentafluoro- 
benzyl-trimethylsilane derivative, the metabolite in peak 7 
co-eluted on gas chromatography  with  authentic LTB,. The 
metabolite  in peak  7 is  LTB,  with only a minor  contamination 
from the  5SJ2S-diHETE isomer. 
Peak IO-Peak 10  co-eluted on reverse phase  HPLC  with 
authentic  5-HETE using solvent  systems 2 and 3 described 
under  "Experimental Procedures." The  formation of peak  10 
was not inhibited by the addition of indomethacin to the 
incubation mixture. Peak 10 is tentatively identified as 5 -  
HETE. 
Quantitation  of  Leukotriene  Formation 
Radioimmunoassays using specific antisera for LTB,  and 
peptide  leukotrienes were used  to  estimate  the  formation of 
these lipids by dog tracheal  epithelial cells. A direct assay of 
the incubation media with a series of dilutions indicated a 
parallelism of the  sample  dilutions  and  the  standard curve. 
Leukotriene formation varied with individual dog prepara- 
tions,  but  the  ratio of LTC, to  LTB, was approximately 1:l. 
Epithelial cells produced approximately 1 ng each of LTC, 
and  LTB4/106 cells (Table 11). 
Effect  of  Exogenous  Arachidonic Acid  Metabolites of  Isc (C1- 
Secretion) 
To  estimate  the relative potencies of arachidonic acid me- 
tabolites  in  inducing C1- secretion  across excised canine  tra- 
cheal epithelium, cumulative additions of authentic com- 
pounds were performed. As shown  in Fig. 7A,  all  PG  products 
increased C1- secretion. However, PGH2, PGD2, and PGE, 
were clearly the most potent and effective metabolites. As 
shown in Fig. 7B, LTC, was the most potent  and effective 
leukotriene  tested.  LTB,  exerted only minor effects, and 5- 
HETE was ineffective.  Because the effect of LTC,  on  canine 
trachea ion transport has not been reported, isotope flux 
measurements were performed to  confirm  that  the  increased 
Isc reflected increased C1- secretion. The results  are shown 
in  Table 111. In six tissue  pairs,  net C1- secretion rose from 
-1.03 5 0.42 peg cm-'  h-' prior  to  stimulation of 1.80 5 0.59 
peq cm-' h" for the 45-min interval after the addition of 
LTC, (A,,, = 0.94 f 0.28 peq cm-' h-'). The  change  in C1- 
secretion  accounted for the  change in Isc. The increase in  net 
flux primarily reflected an increase in  the  unidirectional flux 
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FIG. 7. Relationships between short-circuit current and exogenous AA metabolites for excised canine 
trachea. In panel A ,  the relationship between Isc for indomethacin-pretreated M) excised tracheas and 
cyclooxygenase product additions  are shown. The average Isc immediately prior to agonist addition was 27 pA. 
cm-' and did not significantly differ between groups. Inpanel B, the relationship between basal Isc and lipoxygenase 
product additions is shown. The average Isc prior to addition was 42 pA .cm-' and did not differ between groups. 
Eachpoint represents mean for 5 or more tissues. S.E.  are less than 10% of mean. 
TABLE I1
Estimation of leukotriene formntion by  dog tracheal epithelial cells 
using radioimmunoassays 
~ 
A nimal LTC,  LTB, (n = 3) (n = 3) 
ng/106 cells f S.D. ng/lOE cells f S.D. 
A 1.16 f 0.25 
B 
1.26 f 0.25 
0.76 f 0.22 
C 
0.90 f 0.2 
1.50 f 0.25  1 36 f 0.15 
TABLE I11 
Effect of exogeneous LTC, M) on bioelectric properties and 




PD" (mV) 27.2' f 1.7 32.6' f 2.1 
Isc (PA. cm-') 75.8 +. 7.9 102.9' f 11.6 
G (ms.cm-*) 2.9 f 0.3 3.2' f 0.3 
Ion fluxes (peq cm-' 
h") 
J, MSd Na' 2.49 f 0.54 2.36 f 0.43 
J, SM' Na+ 1.23 f 0.31 1.41 f 0.39 
J, net Na' 1.26' f 0.43 0.95 f 0.48 
J, MS C1- 2.05 f 0.29 2.27 f 0.39 
3, SM C1- 3.08 f 0.41 4.06' f 0.52 
J, net C1- -1.03'f 0.42 -1.8d f 0.57 
Mannitol permeability 9.1 f 1.3 10.3 ? 1.8 
(X  cm s-') 
PD, potential difference. ' Values are the mean f S.E. (n = 6). 
e Different than control value (p < 0.05). 
MS, mucosal to serosal 
e SM, serosal to mucosal 
'Different than zero (p < 0.05)-J, net = secretion. 
in  the  secretory  direction (3.08 f 0.41 eq cm-'  h" for control; 
4.06 * 0.52 peq cm2 h-' after LTC,). No changes were observed 
in  unidirectional  Na+  fluxes  or  mannitol  permeability. 
To test whether LTC, exerted its effect on C1- secretion 
directly, or via an  action  that  required  the  generation of PGs, 
indomethacin  and  other cyclooxygenase inhibitors were added 
to  determine  whether  it  prevented LTC,-induced C1- secre- 
tion. As shown in Fig. 8,  the  LTC, effect was abolished by 
indomethacin regardless of whether the drug was adminis- 
tered before or after LTC, addition. To test whether the 
indomethacin  action was nonspecific or toxic, tissue response 
was measured by the  addition of PGF,,. All tissues showed 
large increases  in Isc in  response  to PGF,, addition. Ibuprofen 
and  naproxen (3 x M) also inhibited  LTC4-induced C1- 
secretion  (data  not  shown).  In six tissue  pairs, Isc for control 
conditions was 81.8 wA. cm-' which increased  to 140 f 47 p A .  
cm-' after addition of M LTC,. In the presence of 3 X 
M ibuprofen the response to LTC, was 94.2 f 30 PA. 
cm-*. Ibuprofen as control gave an Isc of 87.5 f 24 p A .  cm-*. 
We  have  attempted  to directly test for the  stimulation of 
PGD, by LTC, after incorporation of [3H]arachidonic acid 
into cellular  phospholipid. However, the  results were so vari- 
able  that we could not unequivocally show a PGDz increase. 
The variable was observed primarily  with  the  control  samples 
which suggests that  the  manipulation  that occurs with the 
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FIG. 8. Effect  of cumulative additions of indomethacin and 
LTC, on Isc of excised canine tracheas. In one group of tissues, 
indomethacin (3 X M) preceded LTC, (lo-' M) addition (0). In 
another group, indomethacin was added at  the peak of the LTC, 
response (0). The  trend group represents the vehicle (dimethyl sulf- 
oxide)/time control (7). Each group represents 5-7 tissues. Mean f 
S.E. shown. S.E. was equal to  or less than 10% of mean. 
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technique  stimulated  arachidonic acid release. Thus,  the LTC, 
effect on C1- secretion appears to require prostaglandin H 
synthase activity. 
Time Course of Formation of Arachidonic  Acid  Metabolites 
and  Stimulation of C1- Flux  after  A23187 
We attempted  to identify the endogenous compounds that 
stimulate C1- secretion by comparing the time course of 
product generation with the time course of increased C1- 
secretion  in the same cell preparation. The addition of Ca2+ 
and A23187 (1 PM) to  the dog tracheal epithelial cells induced 
a  rapid release of incorporated  [3H]arachidonic acid and me- 
tabolism to prostaglandins and leukotrienes. As shown in Fig. 
9, the metabolism of arachidonic acid was essentially complete 
by 5 min of incubation. All the observed arachidonic acid 
metabolites appeared to be formed within the same time frame 
and preceded the ionophore-induced increase in C1- secretion. 
The initiation in the C1- flux occurred as  the concentration 
of arachidonic acid metabolites  approached  a maximum. 
These results indicate a temporal relationship between the 
formation of prostaglandins and leukotrienes and  the C1- ion 
flux in dog tracheal epithelial cells and suggest that PGD, 
formation precedes C1- ion secretion. 
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FIG. 9. Time course of chloride secretion and arachidonic 
acid metabolism by canine tracheal epithelial cells after ion- 
ophore stimulation. Canine  tracheal epithelial cells were prepared 
as described under “Experimental Procedures.” An intact section of 
canine  trachea was used to study chloride ion flux while the remaining 
trachea was used to provide disaggregated cells that were used to 
examine metabolism. [3H]Arachidonic acid was incorporated into  the 
phospholipid pool and released by the addition of 1 WM A23187. 
Metabolites were isolated and separated as described under “Experi- 
mental Procedures” using solvent system 1. Values are average of 2- 
3 determinations for metabolism and 5-7 determinations for Isc (S.E. 
are less than 10% of mean). 
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FIG. 10. Effect of indomethacin on arachidonic acid metab- 
olism and chloride ion secretion. Chloride ion flux (Isc) and 
arachidonic acid metabolism were carried out  as described in the text. 
Cells were first preincubated for 10 min with indomethacin before 
the addition of 1 p~ A23187. CI- ion secretion was calculated as  an 
increase over basal Isc for each set of chamber. Values are the average 
of 2-3 determinations for metabolism and 6-8 determinations for ion 
secretion. S.E. are less than 10% of mean. 
Effect of Indomethacin  on AA Metabolism  and C1- Secretion 
The addition of indomethacin to  the epithelial cells pro- 
duced a concentration-dependent inhibition of A23187-in- 
duced prostaglandin  formation. At a  concentration of  0.3 KM, 
approximately 70% inhibition of PGD, formation was ob- 
served (Fig. 10). At 30 PM indomethacin, approximately 90% 
inhibition of PGD, formation was observed. Chloride ion flux 
(Isc) was also inhibited by the addition of indomethacin to 
the canine  tracheal  epithelial cells. The inhibition of the C1- 
flux and PGD, formation  appears to occur at similar indo- 
methacin concentrations. Indomethacin also appears to in- 
hibit  leukotriene  formation,  particularly at  the higher concen- 
trations used in this study. However, the formation of the 
metabolites was too variable to be able to determine the 
significance of any apparent effect. 
DISCUSSION 
Freshly isolated canine  tracheal  epithelial cells incorporate 
[3H]arachidonic acid, release arachidonic acid upon exposure 
to  the calcium ionophore, A23187, and metabolize arachidonic 
acid via both prostaglandin H synthase and lipoxygenase 
pathways. The major prostaglandin H synthase metabolite 
produced by the tracheal cells was PGD2. The identification 
of PGD, as the major prostaglandin H synthase product 
differs from previous reports which by radioimmunoassay 
criteria suggested that PGE, was the major prostaglandin  H 
synthase product (4). Several criteria indicate that canine 
tracheal cells in this study generated PGD2: 1) solvent system 
3 produced good separation of PGD2 and PGE,, and peak 3 
co-eluted with authentic  PGDp  rather  than  PGE2 (Fig. 3); 2) 
the derivatized product co-eluted with authentic derivatized 
PGD, on gas chromatographs; 3) mass spectrometry of the 
biosynthetic sample was identical to  authentic PGD,. 
The major lipoxygenase metabolites formed by tracheal 
epithelial cells were LTC, and LTB,. LTB, was identified by 
HPLC analysis, gas chromatography, and UV spectropho- 
tometry. LTC, was characterized by UV spectroscopy, char- 
acteristic  elution of HPLC, radioimmunoassay, and conver- 
sion to LTD, by y-glutamyl  transpeptidase.  LTB, and LTC, 
were synthesized in approximately equal quantities  after 
A23187 stimulation. 
We also observed occasionally an unidentified peptide leu- 
kotriene which did not appear to be LTE,, LTF4, or a leuko- 
triene sulfone or sulfoxide. This metabolite may be a  metab- 
olite or degradation  product of LTC, since the biosyntheses 
of LTC, and the unidentified metabolite were usually in- 
versely related. However, authentic LTC, incubated with the 
epithelial cells was not converted to the metabolite. The 
variability of the cells’ biosynthetic  activity with respect to 
this chemical made the identification of this metabolite dif- 
ficult. 
Arachidonic acid metabolism by  dog tracheal  epithelial cells 
in this study differs somewhat with the  data of Holtzman and 
co-workers (10) and  Smith et al. (4). Like Holtzman et al., we 
observed the synthesis of LTB,. The criteria for identification 
of LTB, in the two studies (HPLC  and spectral  characteris- 
tics) are similar. In contrast to Holtzman et al. (10) we 
observed a significant production of LTC, by dog tracheal 
epithelial cells. The most obvious difference in the two studies 
is the stimulation employed, e.g. exogenous arachidonic acid 
versus A23187, but  the exact reasons for this discrepancy are 
not known. Also, we found that PGD, is the major prosta- 
glandin H  synthase metabolite rather  than PGE, as reported 
by Smith et al. (4) who used the antiserum for PGE,. We have 
good evidence for the formation of PGD, by our cell prepa- 
rations and  can only speculate as  to  the difference between 
Arachidonic  Acid  Metabolism  a d Chl ride  Secretion 12849 
our findings and  that reported by Smith et al. (4). 
Because several of the products identified as metabolites of 
our epithelial  preparations  are also produced by inflammatory 
cells (mast cells and/or polymorphonuclear cells), we evalu- 
ated the possible contamination of our epithelial preparation 
by inflammatory cells by three approaches. First, we per- 
formed a series of morphological evaluations on our cell 
preparations. An evaluation of >7000 cells (7 random prepa- 
rations) by electron microscopy did not reveal mast cells or 
leukocytes. Histologic evaluation of the preparations, employ- 
ing stains for inflammatory cells, also failed to reveal contam- 
ination of the epithelial preparation by inflammatory cells. 
Second, epithelial preparations from disease-free purebred 
beagles  gave identical patterns of arachidonic acid metabolic 
products  as did our  routine  preparations from standard labo- 
ratory animals. Third,  the arachidonic acid metabolic prod- 
ucts of the dog leukocytes were not known and consequently 
were partially characterized.‘ Dog leukocytes metabolize ara- 
chidonic acid to  the  8,E-diHETE- and monooxygenase-cat- 
alyzed metabolites indicating that leukocyte contamination 
would not  contribute to  the  pattern of arachidonic acid prod- 
ucts we have identified. Dog mastocytoma cells in response 
to A23187  oxidize arachidonic acid to a variety of lipoxygenase 
products. The major metabolites were 15-HETE,  12-HETE, 
and  5-HETE. LTB,, LTD,, and  LTC4 were detected but in 
significantly lower amounts (24). We did not observe LTD4, 
12-HETE, or 15-HETE with our canine epithelial prepara- 
tions. Assuming mast cells and mastocytoma cells are similar 
also suggests that mast cells did not  contribute to  the arachi- 
donic acid metabolism by our epithelial cell preparation. The 
data from these  three approaches strongly suggests that  the 
arachidonic acid metabolites identified in our preparations 
after A23187 reflect products of epithelial cells and  not con- 
taminating inflammatory cells. Our preparation  represents all 
cells from the epithelium, i.e. basal, mucus, and ciliated cells. 
Therefore, we cannot assign a role in arachidonic acid metab- 
olism to specific epithelial cell types. 
Our findings suggest that  the epithelia, through the produc- 
tion of these mediators, may play an  important role in mod- 
ulating  functional activities that control the volume and com- 
position of airway secretions. Several lines of evidence indi- 
cate that  the activation of the epithelial C1- path (which may 
control the rate of liquid secretion toward the airway lumen) 
is controlled by the rate of the prostaglandin H synthase- 
dependent PGD, formation. First, the A23187 induced an 
increase in C1- secretion and PGD2 formation. These were 
inhibited by the indomethacin pretreatment indicating a  re- 
quirement for prostaglandin H synthase activity. Second, 
most prostaglandin H synthase metabolites were effective in 
raising C1- secretion. None were inhibitory, suggesting that 
the rate of product formation rather  than  the class of pros- 
taglandin formed is rate limiting for C1- secretion. While 
certain lipoxygenase products were effective in raising C1- 
secretion (LTC, most potently), this effect appeared to be 
indirect and involve cyclooxygenase activity since the LTC,- 
induced activation was blocked  by  cyclooxygenase inhibitors. 
Consistent with this notion is the observation that  the indo- 
methacin-induced inhibition of C1- secretion was correlated 
with the inhibition of prostaglandin H synthase but not 
lipoxygenase. Third, the temporal relationship between the 
prostaglandin H  synthase product formation and  the C1- path 
activation indicates that C1- secretion toward the canine 
tracheal lumen is controlled by PGD, concentration. 
Our data  unfortunately does not allow us to determine the 
T. E. Eling, unpublished observations. 
site(s)  that control the basal rate of C1- secretion in canine 
trachea. Most studies were performed in epithelia stimulated 
with A23187. More importantly, even though LTC, (or  other 
lipoxygenase products) production may exert  its  actions  in- 
directly, the rate of formation of LTC4 still may exert an 
important role in modulating the basal C1- secretory state. 
Our  data indicates the need to focus  on prostaglandin syn- 
thase products in exploring the relationship between arachi- 
donic acid metabolism and C1- secretion. 
Our observation that airway epithelia metabolize arachi- 
donic acid to LTC, and LTB4, as well as prostaglandin H 
synthase products, has two other implications for airway 
physiology. First, LTC, appears to be an important inducer 
of mucin secretion (9). Thus, the rate of mucin addition to 
airway secretions by the airway mucosa  may in  part be deter- 
mined  by “local” stimulation of the epithelium to form mucin 
secretagogues. Second, because LTB, is an important che- 
motactic agent, the production of LTB, by airway epithelia 
may assign an important role in  the development of the airway 
inflammatory response to  the epithelium itself. 
In summary, airway epithelia can metabolize arachidonic 
acid to a variety of products that modulate the flow of salt 
and water, mucin, and migratory cells toward the airway 
lumen. This suggests that studies of the control of arachidonic 
acid metabolism in airway epithelia may yield important 
insights into  the control of mucociliary clearance in health 
and  the pathophysiology of certain diseases that reflect ab- 
normal airway secretion, such as cystic fibrosis or asthma. 
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